Entering text into the input field will update the search result below

Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q1 2020 Results - Earnings Call Transcript

May 06, 2020 8:50 PM ETSarepta Therapeutics, Inc. (SRPT)
SA Transcripts profile picture
SA Transcripts

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET

Company Participants

Ian Estepan - SVP, Chief of Staff and Corporate Affairs

Doug Ingram - President and CEO

Sandy Mahatme - EVP, CFO and Chief Business Officer

Bo Cumbo - EVP and Chief Commercial Officer

Gilmore O'Neill - EVP, R&D and Chief Medical Officer

Louise Rodino-Klapac - SVP, Gene Therapy

Conference Call Participants

Salveen Richter - Goldman Sachs

Brian Abrahams - RBC Capital Markets

Tazeen Ahmad - Bank of America Merrill Lynch

Debjit Chattopadhyay - H.C. Wainwright

Gena Wang - Barclays Capital

Joseph Schwartz - SVB Leerink

Christopher Marai - Nomura

Shawn Egan - Citi

Maxwell Skor - Morgan Stanley

Vincent Chen - Bernstein

Tim Lugo - William Blair

Liisa Bayko - JMP Securities


Good day, ladies and gentlemen, and welcome to the Sarepta Therapeutics First Quarter 2020 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation there will be a question-and-answer session. [Operator Instructions] As a reminder, today's program is being recorded.

And now I would like to introduce your host for today's program, Ian Estepan, Senior Vice President, Chief of Staff and Corporate Affairs. Please go ahead.

Ian Estepan

Thank you all for joining today's call. Earlier today, we released our financial results for the first 2020. The press release is available on our Web site at www.sarepta.com, and our 10-Q was filed with the SEC earlier this afternoon.

Joining us on the call today are Doug Ingram, Sandy Mahatme, Bo Cumbo, Dr. Gilmore O'Neill, and Dr. Louise Rodino-Klapac. After our formal remarks, we'll open up the call for Q&A.

I'd like to note that, during this call, we'll be making a number of forward-looking statements. Please take a moment to review our slides on the webcast, which contains

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.